2 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow [18F]THK-5351: new trials by email Literature Review of [18F]THK-5351 trials Research Report on [18F]THK-5351
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome [18F]THK-5351, [18F]AV-45 - Post-stroke Dementia, Vascular Mild Cognitive Impairment | Phase 2 | Unknown | Chang Gung Memorial Hospital | 200 | 2017-06-01 | 2023-05-06 |
| A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease [18F]THK-5351 - Alzheimer Disease | Phase 1 | Completed | Asan Foundation | 12 | 2017-05-17 | 2020-12-14 |
| [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [18F]THK-5351 - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Completed | Jae Seung Kim | 135 | 2016-01-11 | 2020-12-14 |
Alzheimer Disease (2) · Nerve Degeneration (2) · Pick Disease of the Brain (2) · Cognitive Dysfunction (1) · Neurodegenerative Diseases (1)
Asan Foundation (1) · Chang Gung Memorial Hospital (1) · Jae Seung Kim (1)
South Korea (2) · Taiwan (1)
Huang Kuo-Lun, M.D. (1) · Jae Seung Kim, M.D.,Ph.D. (1) · JaeEun Kim (1)